TBM-Infarct

N/A

Report date: 2025/03/20 09:36:24
NME

Base Information

Drug NameTBM-Infarct
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyocardial Reperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTarga Biomedical
China Registration ClassN/A

Develop Information

Active CompaniesTarga Biomedical
Inactive CompaniesN/A
Active IndicationsMyocardial Reperfusion Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A